Biodesix (BDSX) insider buying

Healthcare · Diagnostics & Research · Market cap $255M

3 open-market purchases of BDSX by Biodesix's executives and directors since January 2026, worth $2M in total, from SEC Form 4 filings.

The most recent: Jack W Schuler bought $236,000 on January 26, 2026.

The biggest buyer over the period is Jack W Schuler: 3 purchases, $2M.

By year

YearPurchasesValue
20263$2M

Biggest buyers

InsiderBuysValue
Jack W Schuler
3$2M

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Jan 26, 2026 Jack W Schuler
 20,000$11.80$236,000 Form 4
Jan 23, 2026 Jack W Schuler
 80,000$11.81$944,800 Form 4
Jan 22, 2026 Jack W Schuler
 82,465$10.96$903,816 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BDSX.
Open BDSX in Investingly

Questions

Are Biodesix insiders buying the stock?

3 open-market purchases of BDSX by Biodesix's executives and directors since January 2026, worth $2M in total, from SEC Form 4 filings. The most recent: Jack W Schuler bought $236,000 on January 26, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Biodesix's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.